1. Home
  2. VCIG vs ENSC Comparison

VCIG vs ENSC Comparison

Compare VCIG & ENSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VCIG
  • ENSC
  • Stock Information
  • Founded
  • VCIG 2013
  • ENSC 2003
  • Country
  • VCIG Malaysia
  • ENSC United States
  • Employees
  • VCIG N/A
  • ENSC N/A
  • Industry
  • VCIG Diversified Commercial Services
  • ENSC Biotechnology: Pharmaceutical Preparations
  • Sector
  • VCIG Consumer Discretionary
  • ENSC Health Care
  • Exchange
  • VCIG Nasdaq
  • ENSC Nasdaq
  • Market Cap
  • VCIG 5.3M
  • ENSC 5.2M
  • IPO Year
  • VCIG 2023
  • ENSC N/A
  • Fundamental
  • Price
  • VCIG $1.23
  • ENSC $2.24
  • Analyst Decision
  • VCIG
  • ENSC
  • Analyst Count
  • VCIG 0
  • ENSC 0
  • Target Price
  • VCIG N/A
  • ENSC N/A
  • AVG Volume (30 Days)
  • VCIG 6.4M
  • ENSC 92.0K
  • Earning Date
  • VCIG 08-18-2025
  • ENSC 08-13-2025
  • Dividend Yield
  • VCIG N/A
  • ENSC N/A
  • EPS Growth
  • VCIG N/A
  • ENSC N/A
  • EPS
  • VCIG 54.73
  • ENSC N/A
  • Revenue
  • VCIG $27,819,290.00
  • ENSC $6,224,081.00
  • Revenue This Year
  • VCIG N/A
  • ENSC N/A
  • Revenue Next Year
  • VCIG N/A
  • ENSC $1,381.48
  • P/E Ratio
  • VCIG $0.02
  • ENSC N/A
  • Revenue Growth
  • VCIG 36.99
  • ENSC 256.35
  • 52 Week Low
  • VCIG $0.88
  • ENSC $1.62
  • 52 Week High
  • VCIG $519.20
  • ENSC $14.67
  • Technical
  • Relative Strength Index (RSI)
  • VCIG 38.86
  • ENSC 52.50
  • Support Level
  • VCIG $0.90
  • ENSC $2.08
  • Resistance Level
  • VCIG $1.07
  • ENSC $2.27
  • Average True Range (ATR)
  • VCIG 0.17
  • ENSC 0.17
  • MACD
  • VCIG 0.06
  • ENSC 0.01
  • Stochastic Oscillator
  • VCIG 43.75
  • ENSC 62.79

About VCIG VCI Global Limited

VCI Global Ltd is a holding company. The principal activities of the Company and its subsidiaries are the provision of business Strategy consultancy and technology development. The firm organized its consulting services into three main segments: Business Strategy Consultancy; Technology development, solutions and consultancy; and Others. It derives the majority of its revenue from the Business Strategy Consultancy segment, which focuses on listing solutions, investor relations, and boardroom strategies consultancy.

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

Share on Social Networks: